Drug archive
Neomycin, Polymyxin B, and Gramicidin (Ophthalmic)Before Using
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Before Using This Medicine
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For neomycin, polymyxin B, and gramicidin ophthalmic drops, the following should be considered:
Allergies - Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or to any related antibiotic, such as amikacin (e.g., Amikin), colistimethate (e.g., Coly-Mycin M), colistin (e.g., Coly-Mycin S), gentamicin (e.g., Garamycin), kanamycin (e.g., Kantrex), netilmicin (e.g., Netromycin), paromomycin (e.g., Humatin), streptomycin, or tobramycin (e.g., Nebcin). Also tell your health care professional if you are allergic to any other substances, such as preservatives.
Pregnancy - Neomycin, polymyxin B, and gramicidin combination has not been shown to cause birth defects or other problems in humans.
Breast-feeding - Neomycin, polymyxin B, and gramicidin combination has not been reported to cause problems in nursing babies.
Children - Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of this combination in children with use in other age groups.
Older adults - Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of neomycin, polymyxin B, and gramicidin combination in the elderly with use in other age groups.